Original Title: 국내 정신질환 관련 연구현황 파악 및 우울증 자살에 대한 연구: 3 세부 : 암과 당뇨병 환자에서 우울증 동반현황과 치료증진방안 연구

Authors' recommendations: The analysis of the national claims data regarding depression in cancer patients showed that an estimated 13.2% of cancer patients were being treated at medical institutions for depression. Based on the patient characteristics recorded on the first consultation for depression treatment, an analysis showed that the severity of depression manifested by suicide attempt, admission, or visit to the emergency room were higher in males, metastatic cancer, lung cancer, or liver cancer patients, patients treated at multiple medical institutions, and those who frequently visit medical facilities for treatment. According to the analysis of KNHANES Ⅳ (2007-2009), 25% of cancer patients experienced depression. However, only 4.3% was diagnosed with depression by a physician, showing a high discrepancy. The analysis of the national claims data showed that 16.2% of diabetic patients visited medical institutions for depression. After the diagnosis for depression (Ed note: this is okay; but consider: 'After being diagnosed as depression,…'), the cities with higher rates of compliance with antidepressant medications had increased compliance with oral hypoglycemic agents. Those who also experienced cardio-cerebrovascular complications were 63.1% of diabetic patients with co-occurring depression, 43.8% experienced ophthalmic complications, and 24.2% experienced co-occurring neuropathies. Compared to patients without co-occurring diabetes, those with co-occurring diabetes or diabetic complications experienced higher rate of depression aggravation (co-occurrence of microvascular and macrovascular complications, odds ratio = 2.20). The Fourth Korea National Health and Nutrition Examination Survey showed that 18.6% of diabetics experienced depressive symptoms, which were lower in prevalence than cancer patients. The results of this study showed the following: 1) we determined that the prevalence and treatment needs of mental illness were high in Korea; 2) we confirmed the geographical distribution and risk factors for adolescent depression and suicide; and 3) we determined the needs of treatments for many depressive patients with cancer or diabetes, and suggested evidences to deduce ways to enhance the treatments. Based on this study, it is necessary that we expand the range of psychiatric disorder-related research in the future and develop measures to increase the utilization of psychiatric services. Furthermore, if systematic treatment measures are developed in preventing adolescent depression and suicide as well as comorbidities, subsequent effective treatment of depression will reduce the distress caused by mental illness in the general society.

Project Status: Completed

Year Published: 2012

URL for published report: https://www.neca.re.kr/lay1/program/S1T11C145/report/view.do?seq=39

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: South Korea

Organisation Name: National Evidence-based healthcare Collaborating Agency

Contact Address: National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.

Contact Name: int@neca.re.kr

Contact Email: int@neca.re.kr

Copyright: National Evidence-based Healthcare Collaborating Agency (NECA)